Click here for updates to closures, protocols, sanitizing & current news regarding The Blood Center's response to the COVID virus.
This is part of an investigational initiative approved by the FDA for use in the treatment of seriously ill patients fighting COVID-19.
Antibodies from convalescent plasma could help patients “fight off’ severe viral infections. This is the same kind of therapy that was used to combat SARS and MERS with some success.
We request potential donors please enroll in Louisiana’s registry at tbc.bio-linked.org. Bio-Linked allows users to submit confidential health and social information via a secure site and to list themselves as potential volunteers for investigational medical treatment. Once qualified, plasma will be drawn, with each donor providing up to three therapeutic plasma doses.
To provide convalescent plasma, donors must be eligible to donate blood and meet the criteria below:
The Blood Center is not testing for active COVID-19 infection. In an effort to locate and recruit more potential Convalescent Plasma donors, all blood donations are being screened for COVID-19 Antibodies.
About the process: In a plasma donation, blood drawn from the donor’s arm goes first to a cell separator machine. The plasma is separated and sent to a collection bag, and the remaining components are returned to the donor. The entire process in total takes about 45 minutes and provides up three therapeutic plasma doses.